Systemic Immune-Inflammatory Index, Tumor-Infiltrating Lymphocytes, and Clinical Outcomes in Esophageal Squamous Cell Carcinoma Receiving Concurrent Chemoradiotherapy

Figure 6

Kaplan–Meier survival curve of combination prognostic role of SII and TIL. (a) OS in different combinations was evaluated by TIL concentration and SII score. (b) PFS in different combinations was evaluated by TIL concentration and SII score. OS, overall survival; PFS, progression-free survival; TIL, tumor-infiltrating lymphocytes; SII, systemic immune-inflammation index.

(a)

(b)